Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0001062993-23-010808

Options or other derivatives

  • Director acquired 8,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Truitt Joseph Director 2023-05-09 Grant or award · Stock Option (Right to Buy) +8,300 8,300 D
Loading xslF345X04/form4.xml…